According to a recent FCC filling, Alphabet’s Life Sciences wing Verily has recently developed a new “Connectivity Bridge” for use in clinical studies. The device is capable of collecting and syncing medical information of people participating in clinical studies, allowing Google to continue to improve its efforts in healthcare.
Now that the Alphabet restructuring is kicking into gear, the company today has renamed its experimental health care branch. The branch was originally named Google Life Sciences, but from here on out will be known as “Verily.” The goals of Verily are identical to Life Sciences and the only thing that’s really changing is the name.
The then-under-Google X Life Sciences team made its “capicola” health tracker official in an interview with Bloomberg earlier this year, but until now we’ve only seen one stock image of the device. Andy Conrad, head of the life sciences team, was quoted at the time as saying that this device is to be used primarily for medical purposes, such as prescribed to patients or used in clinical trials. Now, we have another look at the device — which has the FCC ID A4R-CAP1 — in a little more detail…
Expand
Expanding
Close
According to a new report from The Wall Street Journal, Google’s (now Alphabet’s) Life Sciences is adding another company to a growing list of partners that are helping the group explore new technologies for disease treatment and prevention. Specifically, the Life Sciences group, led by the to-be-CEO Andrew Conrad under Alphabet, has agreed to work with European pharmaceutical company Sanofi on new ways to treat and monitor diabetes…
Expand
Expanding
Close
The Life Sciences group at Google, previously under the umbrella of the company’s experimental X lab, seems to now be holding its own under the newly-formed Alphabet parent company. It’s something that somehow went under the radar with Larry Page’s announcement of Alphabet, but it’s definitely notable. It’s yet another graduation from the skunkworks lab, and it’s recognition that the group is worthy of being its own company…
Expand
Expanding
Close
With the announcement that Google has completely reorganized its entire business under a new parent company called Alphabet, there are still many questions floating around about what products belong with what companies now.
Thanks to Google’s SEC filing, we’ve got some answers on that front.
[youtube https://www.youtube.com/watch?v=7dzI_azZEGI]
The Atlantic got to take an exclusive look inside Google’s medical sciences lab, where the company is developing crazy new technologies like a FitBit-style armband paired with a nanoparticle-laden pill that can detect cancer—a technology first noted as being in development by 9to5Google last June.
Also, they’re making fake arms out of real skin. Yes, real human skin.
